BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32631368)

  • 1. Rapid exacerbation featuring acute leukemoid reaction after retrolaparoscopic nephrectomy: a rare case report of renal cell carcinoma with postoperative comprehensive genomic profiling.
    Zhang X; Yan L; Yuan X; Bai T; Zhang L; Han S
    World J Surg Oncol; 2020 Jul; 18(1):155. PubMed ID: 32631368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemoid reaction in sarcomatoid renal cell carcinoma: a two-case report.
    Huang W; Wang F; Li Y; Duan F; Yu Z
    World J Surg Oncol; 2014 Apr; 12():100. PubMed ID: 24745762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Genomic Profiling of Renal Cell Carcinoma at Initial Diagnosis and Putative Local Recurrence.
    Chalmers ZR; Johnson A; Ali SM; Frampton GM; Miller V; Ross JS; Pal SK
    Eur Urol Focus; 2018 Mar; 4(2):267-269. PubMed ID: 28753749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bilateral papillary renal cell carcinoma following kidney transplantation: A case report].
    Hong P; Tian XJ; Zhao XY; Yang FL; Liu Z; Lu M; Zhao L; Ma LL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):811-813. PubMed ID: 34393251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
    Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
    Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral Xp11.2 translocation renal cell carcinoma: a case report.
    Karashima T; Kuno T; Kuroda N; Satake H; Fukata S; Chikazawa M; Kawada C; Yamasaki I; Shuin T; Hiroi M; Inoue K
    BMC Urol; 2018 Nov; 18(1):106. PubMed ID: 30458744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes.
    Psutka SP; Heidenreich M; Boorjian SA; Bailey GC; Cheville JC; Stewart-Merrill SB; Lohse CM; Atwell TD; Costello BA; Leibovich BC; Thompson RH
    BJU Int; 2017 Jan; 119(1):116-127. PubMed ID: 27489013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of 30-day acute kidney injury following radical and partial nephrectomy for renal cell carcinoma.
    Schmid M; Abd-El-Barr AE; Gandaglia G; Sood A; Olugbade K; Ruhotina N; Sammon JD; Varda B; Chang SL; Kibel AS; Chun FK; Menon M; Fisch M; Trinh QD
    Urol Oncol; 2014 Nov; 32(8):1259-66. PubMed ID: 25129142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma producing granulocyte colony-stimulating factor.
    Wang YC; Yang S; Tzen CY; Lin CC; Lin J
    J Formos Med Assoc; 2006 May; 105(5):414-7. PubMed ID: 16638652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal fossa recurrence after radical nephrectomy: Current management, and oncological outcomes.
    Romeo A; Garcia Marchiñena P; Jurado AM; Gueglio G
    Urol Oncol; 2020 Feb; 38(2):42.e7-42.e12. PubMed ID: 31711833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Camera-port site metastasis of a renal-cell carcinoma after robot-assisted partial nephrectomy.
    Song JB; Tanagho YS; Kim EH; Abbosh PH; Vemana G; Figenshau RS
    J Endourol; 2013 Jun; 27(6):732-9. PubMed ID: 23297710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
    Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
    World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.
    Ghavamian R; Cheville JC; Lohse CM; Weaver AL; Zincke H; Blute ML
    J Urol; 2002 Aug; 168(2):454-9. PubMed ID: 12131287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hilar location is an independent prognostic factor for recurrence in T1 renal cell carcinoma after nephrectomy.
    Shim M; Song C; Park S; Kim A; Choi SK; Kim CS; Ahn H
    Ann Surg Oncol; 2015 Jan; 22(1):344-50. PubMed ID: 25323469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery.
    Shapiro DD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Jarrard DF; Richards KA; Downs TM; Allen GO; Nakada SY; Abel EJ
    Urology; 2020 Jan; 135():88-94. PubMed ID: 31585198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical management for local retroperitoneal recurrence of 33 renal cell carcinoma patients underwent radical nephrectomy].
    Huang JW; Cai W; Kong W; Zhang J; Chen YH; Huang YR
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):703-707. PubMed ID: 31550862
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transitional cell carcinoma with extension of the renal vein and IVC tumor thrombus: report of three cases and literature review.
    Li M; Shi A; Kong W; Zhang J; Chen Y; Huang J; Huang Y
    World J Surg Oncol; 2016 Dec; 14(1):309. PubMed ID: 28031042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report.
    Kamai T; Abe H; Arai K; Murakami S; Sakamoto S; Kaji Y; Yoshida KI
    BMC Cancer; 2016 Mar; 16():232. PubMed ID: 26983443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study.
    Ierardi AM; Carnevale A; Rossi UG; Renzulli M; Garanzini E; Golfieri R; Macchione N; Cittanti C; Giganti M; Carrafiello G
    Med Oncol; 2020 Mar; 37(4):27. PubMed ID: 32166412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.